Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
43 Leser
Artikel bewerten:
(0)

Global Vascular Stents (Coronary & Peripheral) Market 2016 - Forercasts to 2020 - Research and Markets

DUBLIN, July 12, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Vascular Stents Market 2016-2020" report to their offering.

The global vascular stents market to grow at a CAGR of 7.38% during the period 2016-2020.

Global Vascular Stents Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The device helps prevent arterial blockages that may occur in people who have undergone angioplasty. It helps maintain the patency of stenotic vessels and avoid re-blockage due to blood accumulation or excessive tissue growth.

A trend which will definitely change the market is the emergence of bio-absorbable stents. Since 1995, the introduction of new products such as bio-absorbable scaffolds, biodegradable polymers, and bifurcation stents is likely to increase the use of vascular stents in interventional cardiology. These stents have the potential to eliminate the complications of durable polymer stents.

This will induce a significant positive shift in the treatment of artery stenosis and encourage affected individuals to undergo vascular stenting. Bio-absorbable stents restore blood flow by opening the clogged blood vessel and provide support until the damaged blood vessel heals. Unlike metallic stents, the body gradually metabolizes the bio-absorbable stent and entirely absorbs them over time.
According to the report, a key growth driver is the demand for minimally invasive procedures. Minimally invasive procedures involve smaller incisions. They help prevent excessive blood loss and reduce the duration of recovery and hospital stay. These surgeries also reduce the need for blood transfusions and the risk of infections, cause less pain and scarring, and lead to the better clinical outcome. They help treat individuals who are in critical conditions or ineligible for open surgeries.

These benefits of minimally invasive procedures have led surgeons to implement them for managing different disorders such as an aneurysm, artery stenosis, and plaque in the blood vessel of the heart and other vessel walls of peripheral organs. Physicians are using minimally invasive peripheral vascular stenting to treat chronic limb ischemia.

Further, the report states that one challenge that could restrict market growth is the complications associated with vascular stenting.

To calculate the market size, we consider revenue generated from the sales of:

- Coronary stents: Drug-eluting, bare metal, and bioabsorbable stents
- Peripheral vascular stent: Iliac artery, fem-pop artery stents, renal artery, and carotid artery stents

Key vendors

- Abbott Laboratories
- Boston Scientific
- Cook Medical
- Cordis
- Medtronic
- W.L. Gore & Associates

Other prominent vendors

- AMG International
- B. Braun Melsungen
- Biosensors International
- BIOTRONIK
- Fortimedix
- Gore Medical
- InspireMD
- Lepu Medical Technology
- MicroPort Scientific
- Optimed
- Neovasc
- Sorin Group
- Terumo

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Vascular stents: An overview

Part 06: Market landscape

Part 07: Market segmentation by product type

Part 08: Global coronary stents market

Part 09: Global peripheral stents market

Part 10: Geographical segmentation

Part 11: Market drivers

Part 12: Impact of drivers

Part 13: Market challenges

Part 14: Impact of drivers and challenges

Part 15: Market trends

Part 16: Vendor landscape

Part 17: Appendix

For more information visit http://www.researchandmarkets.com/research/zmdj5c/global_vascular

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

© 2016 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.